In August 2023, a patient filed both Ozempic and Mounjaro lawsuits after experiencing severe gastroparesis after taking both drugs
An intensive discussion on the pancreatic safety of incretin-based therapies initiated by publications of a single group have led to a thorough evaluation of non-clinical and clinical data by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) (3845)
For those who have attempted diet, exercise, or even surgery to no avail, it might be a promising alternative
Products containing bitter melon, cinnamon, fenugreek, or other herbs that may affect glucose metabolism or gastric motility should be discussed with the prescribing provider, as additive effects with tirzepatide are possible
Testing shows the product is 99.6% pure, with an assay result of 99.8%, meaning the material closely matches what it is supposed to be